Lyophilized Fecal Microbiome Transfer vs. Vancomycin Monotherapy for Primary Clostridioides Difficile Infection

NARecruitingINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

November 15, 2023

Primary Completion Date

November 30, 2025

Study Completion Date

March 31, 2026

Conditions
Clostridioides Difficile Infection
Interventions
COMBINATION_PRODUCT

Lyophilized fecal microbiome transfer

Five days of vancomycin followed by five days of lyophilized fecal microbiome transfer, administered in a loading dose of 15 capsules, and a daily maintenance dose of 10 capsules.

DRUG

Vancomycin

Ten days of oral vancomycin 125 mg four times daily

Trial Locations (6)

Unknown

RECRUITING

University of Alberta, Edmonton

NOT_YET_RECRUITING

University of Debrecen, Debrecen

RECRUITING

Rambam Health Care Campus, Haifa

NOT_YET_RECRUITING

Gemelly institute Policlinico Universitario Fondazione Agostino Gemelli, Rome

NOT_YET_RECRUITING

Hospital of Lithuania University of Health Sciences Kauno klinikos, Kaunas

NOT_YET_RECRUITING

Imperial College of London, London

All Listed Sponsors
collaborator

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

collaborator

European Institute of Oncology

OTHER

collaborator

University of Alberta

OTHER

collaborator

Imperial College London

OTHER

collaborator

University of Debrecen

OTHER

collaborator

Lithuanian University of Health Sciences

OTHER

lead

Rambam Health Care Campus

OTHER